Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 143952
                    [Title] => New treatment for age-old blindness
                    [Summary] => A new treatment for age-related macular degeneration (AMD), a disease that affects 30 million people worldwide and is the leading cause of blindness in people over 50, was recently introduced by Novartis Healthcare Phils. Inc. to members of the Vitreoretina Society of the Philippines and the Philippine Academy of Ophthalmology at the Makati Shangri-La Hotel recently.


                    [DatePublished] => 2001-12-17 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

KOREA RETINAL SOCIETY

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 143952
                    [Title] => New treatment for age-old blindness
                    [Summary] => A new treatment for age-related macular degeneration (AMD), a disease that affects 30 million people worldwide and is the leading cause of blindness in people over 50, was recently introduced by Novartis Healthcare Phils. Inc. to members of the Vitreoretina Society of the Philippines and the Philippine Academy of Ophthalmology at the Makati Shangri-La Hotel recently.


                    [DatePublished] => 2001-12-17 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

New treatment for age-old blindness

December 17, 2001 - 12:00am

A new treatment for age-related macular degeneration (AMD), a disease that affects 30 million people worldwide and is the leading cause of blindness in people over 50, was recently introduced by Novartis Healthcare...

Science and Environment